Increasing the Accuracy, Speed, Efficiency & Ease of Use of Infectious Disease Diagnostics
Company Overview
Molecular Detection Inc. (MDI) is applying its proprietary technologies to develop and market Detect-Ready® molecular diagnostic tests to increase the speed, accuracy, ease of use, and efficiency of infectious disease diagnosis.
Molecular Detection is developing and commercializing a portfolio of sample-to-answer Detect-Ready® molecular diagnostic tests for the rapid detection of infectious diseases.
Detect-Ready® MRSA Panel Introduction
The Detect-Ready® MRSA Panel is a qualitative real-time PCR (rt-PCR) in vitro diagnostic test for the rapid differential detection of methicillin-sensitive and methicillin-resistant S. aureus (MSSA and MRSA) colonization to aid in the prevention and control of MRSA, MSSA and related infections in hospitals and other healthcare settings. The Detect-Ready ready-to-use pre-mixed reagents require only the addition of DNA from the patient sample to run the panel, which provides test results in less than three hours.
Get in Touch with Us
Want to learn more about Molecular Detection or have a question about our approach? Use the contact form and let’s start a conversation.